Sort
261,768 grants matching “gene therapy”
Genetic and Molecular Epidemiology of Adult Glioma
$1,110,511Margaret R. Wrensch · University Of California, San Francisco · R01 · FY2009 · CA
NeuroAIDS Therapeutics-Targeting Immune Polarization of Macrophages in CNS
$1,110,500Jay Rappaport · Temple Univ Of The Commonwealth · P01 · FY2014 · MH
TGF-betas in breast cancer progression
$1,110,311Lalage Wakefield · Basic Sciences · Z01 · FY2007 · CA
Improved Chimeric Antigen Receptor Therapies B-cell Malignancies
$1,110,078James Kochenderfer · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Combating resistant superbugs by understanding the molecular determinants of target site penetration and binding
$1,110,059Jurgen Bernd Bulitta · University Of Florida · R01 · FY2020 · AI
Initiation of DNA Replication in Mammalian Cells
$1,110,045Mirit Aladjem · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Translational Research in the Dystrophinopathies
$1,109,988University Of Utah · R01 · FY2002 · NS
Inhibition Of Renal Injury
$1,109,680Robert A Star · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Proteogenomic characterization of early and late resistance mechanisms in acute myeloid leukemia
$1,109,637Jeffrey Wallace Tyner · Oregon Health & Science University · U01 · FY2024 · CA
Mechanisms of Effective Humoral Immune Responses to HIV-1
$1,109,557Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer
$1,109,454John D Minna · Ut Southwestern Medical Center · P50 · FY2019 · CA
Disease Modifying Analgesia with CA8 Gene Therapy
$1,109,446Roy Clifford Levitt · University Of Miami School Of Medicine · UH3 · FY2023 · NS
Genes contributing to nicotine dependence in humans
$1,109,442Kari Stefansson · Decode Genetics, Inc. · R01 · FY2008 · DA
PRINT: Nanoparticles: "Calibration Quality" Nano-tools for Studying the Effect of
$1,109,385Joseph M Desimone · Univ Of North Carolina Chapel Hill · U54 · FY2012 · CA
Novel and Kidney Selective AMPK Activators to Treat Polycystic Kidney Disease
$1,109,281Ken W Batchelor · Novatarg, Inc. · R44 · FY2016 · DK
Molecular prostheses for mitochondrial disorders
$1,108,906Vamsi Krishna Mootha · Massachusetts General Hospital · R01 · FY2011 · GM
PRECLINICAL MOUSE: CENTRAL NERVOUS SYSTEM CANCERS
$1,108,628University Of North Carolina Chapel Hill · U01 · FY2002 · CA
Pennington/Louisiana NORC
$1,108,618Leanne Maree Redman · Lsu Pennington Biomedical Research Ctr · P30 · FY2024 · DK
Pennington/Louisiana NORC
$1,108,618Eric Ravussin · Lsu Pennington Biomedical Research Ctr · P30 · FY2023 · DK
Pennington/Louisiana NORC
$1,108,618Eric Ravussin · Lsu Pennington Biomedical Research Ctr · P30 · FY2025 · DK
Intersection of Obesity and Heart Failure with Preserved Ejection Fraction
$1,108,586David Alan Kass · Johns Hopkins University · R35 · FY2024 · HL
Stem Cell Toxicology
$1,108,550Erik Tokar · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES
Preclinical evaluation of a potent Lassa fever immunotherapeutic antibody cocktail
$1,108,530Robert F Garry · Tulane University Of Louisiana · R01 · FY2020 · AI
Circuit-specific, chemogenetic neuromodulation in nonhuman primates.
$1,108,413Charles E Schroeder · Nathan S. Kline Institute For Psych Res · UG3 · FY2024 · MH
Engineering and Imaging 3D genome structure-function dynamics across time scales
$1,108,388Jennifer Elizabeth Phillips-Cremins · University Of Pennsylvania · U01 · FY2022 · DK